Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.

Human immunity acquired after cholera or provided by cholera vaccines was evaluated. Previous diarrhea caused by infection with Vibrio cholerae induced complete protection against diarrhea after a second challenge with the homologous organism four to 12 months later; vibrios were recovered from only one of 21 patients challenged with the homologous organism. Four of six other men challenged again after the same interval with a heterologous serotype developed mild diarrhea. A whole-cell Inaba vaccine, given either parenterally or orally, produced significant protection against excretion of the organisms and lowered the incidence and severity of diarrhea; the vaccine was more effective when administered parenterally. A partially purified toxoid vaccine also provided some protection. An individual's immunity either to infection or to diarrhea was not correlated with his serum titer of vibriocidal antibody or his serum titer of antitoxin. Immunity, either naturally acquired or vaccine-induced, appeared to be directed against the vibrio rather than against the toxin. At present, cholera vaccines are less effective than previous infection in prevention of subsequent illness.

[1]  R. Freter Detection of Coproantibody and its Formation after Parenteral and Oral Immunization of Human Volunteers. , 1962 .

[2]  R. Wenzel,et al.  Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. , 1974, The Journal of infectious diseases.

[3]  W. Woodward Cholera reinfection in man. , 1971, Journal of Infectious Diseases.

[4]  H. D. Hochstein,et al.  Titration of Cholera Antitoxin Levels by Passive Hemagglutination Tests Using Fresh and Formalinized Sheep Erythrocytes 1 , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[5]  G. J. Kasai,et al.  The titration of cholera toxin and antitoxin in the rabbit ileal loop. , 1966, The Journal of infectious diseases.

[6]  S. Mukerjee,et al.  Live oral cholera vaccine: report of a trial on human volunteer subjects. , 1969, Bulletin of the World Health Organization.

[7]  W. Burrows,et al.  Studies on immunity to Asiatic cholera. VII. Prophylactic immunity to experimental enteric cholera. , 1953, The Journal of infectious diseases.

[8]  J. Feeley,et al.  PASSIVE SERUM PROTECTION OF THE INFANT RABBIT AGAINST EXPERIMENTAL CHOLERA. , 1964, The Journal of infectious diseases.

[9]  R. Sack,et al.  Magnitude and duration of antitoxic response to human infection with Vibrio cholerae. , 1970, The Journal of infectious diseases.

[10]  K. Aziz,et al.  The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests. , 1970, The Journal of infectious diseases.

[11]  R. Freter,et al.  ORAL IMMUNIZATION AND PRODUCTION OF COPROANTIBODY IN HUMAN VOLUNTEERS. , 1963, Journal of immunology.

[12]  F. Chisari,et al.  Response of monkeys to immunization with cholera toxoid, toxin, and vaccine: reversion of cholera toxoid. , 1972, The Journal of infectious diseases.

[13]  T. Yoshikawa,et al.  Concentrations of Trimethoprim-Sulfamethoxazole in Blood After a Single, Large Oral Dose , 1976, Antimicrobial Agents and Chemotherapy.

[14]  W H Mosley,et al.  A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate. , 1968, Bulletin of the World Health Organization.

[15]  H. D. Hochstein,et al.  Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes. , 1970, Applied microbiology.

[16]  A. Cruz,et al.  A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines. , 1967, Bulletin of the World Health Organization.

[17]  A. Benenson,et al.  FIELD TRIAL OF CHOLERA VACCINE IN RURAL EAST PAKISTAN. FIRST YEAR OF OBSERVATION. , 1965, Lancet.

[18]  K. Bhaskaran,et al.  Attenuation of virulence in Vibrio cholerae , 1967, Journal of Hygiene.

[19]  W. Mosley,et al.  Ineffectiveness of cholera vaccination as an epidemic control measure. , 1973, Lancet.